Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing NaN - NaN of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Canada, United States (Tivozanib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Mobile, Alabama
  • +24 more
Oct 5, 2020

Magnetic Resonance Imaging in Predicting Response to Sunitinib

Completed
  • Renal Cell Carcinoma
  • +2 more
  • mutation analysis
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jun 21, 2019

Renal Cell Carcinoma Trial in Philadelphia (Optison)

Completed
Has Results
  • Renal Cell Carcinoma
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Apr 29, 2019

Renal Cell Carcinoma, Kidney Cancer Trial in United States (124-Iodine-cG250 (124I-cG250), CT)

Completed
Has Results
  • Renal Cell Carcinoma
  • Kidney Cancer
  • 124-Iodine-cG250 (124I-cG250)
  • CT
  • Los Angeles, California
  • +13 more
Sep 3, 2018

Renal Cell Carcinoma Trial in Philadelphia (CRLX101 (Cerulean), Bevacizumab)

Completed
  • Renal Cell Carcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Aug 27, 2018

Renal Cell Carcinoma Trial in Philadelphia (EC17)

Completed
  • Renal Cell Carcinoma
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Jun 29, 2018

Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

Terminated
  • Advanced Renal Cell Carcinoma
  • +2 more
  • Standard Treatment
  • AGS-003
  • Scottsdale, Arizona
  • +124 more
Jun 13, 2018

Renal Cell Carcinoma, Mantle-Cell Lymphoma, Diffuse, Large B-Cell, Lymphoma Trial in United States (SGN-CD70A)

Completed
  • Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
  • +16 more
Apr 18, 2018

Renal Cell Carcinoma Trial in United States (Perifosine)

Completed
  • Renal Cell Carcinoma
  • Duarte, California
  • +3 more
Feb 27, 2018

Renal Cell Carcinoma, Kidney Cancer Trial in United States (Iodine (124I) Girentuximab)

Withdrawn
  • Renal Cell Carcinoma
  • Kidney Cancer
  • Iodine (124I) Girentuximab
  • Los Angeles, California
  • +7 more
Dec 20, 2017

Renal Cell Carcinoma Trial in Philadelphia (Perflutren Protein-Type A Microspheres, Dynamic Contrast-Enhanced Ultrasound

Withdrawn
  • Renal Cell Carcinoma
  • Perflutren Protein-Type A Microspheres
  • Dynamic Contrast-Enhanced Ultrasound Imaging
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 13, 2017

Melanoma, Lung Cancer, Renal Cell Carcinoma Trial in Canada, United States (Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF

Completed
  • Melanoma
  • +3 more
  • Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)
  • Billings, Montana
  • +3 more
Nov 30, 2015

Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Pancreatic Cancer Trial in Philadelphia, Oslo, Manchester (ABR-217620)

Completed
  • Non-Small-Cell Lung Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
  • +2 more
Aug 26, 2014

Renal Cell Carcinoma, Metastases Trial in United States (Avastin (bevacizumab), Tarceva (erlotinib HCl))

Completed
  • Renal Cell Carcinoma
  • Metastases
  • Avastin (bevacizumab)
  • Tarceva (erlotinib HCl)
  • Concord, California
  • +19 more
May 14, 2014

Papillary Thyroid Cancer, Follicular Thyroid Cancer, Huerthle Cell Thyroid Cancer Trial in United States (rosiglitazone, XL184)

Completed
  • Papillary Thyroid Cancer
  • +3 more
  • Duarte, California
  • +4 more
Sep 17, 2013

Renal Cell Carcinoma Trial in Worldwide (autologous human tumor-derived HSPPC-96)

Completed
  • Renal Cell Carcinoma
  • autologous human tumor-derived HSPPC-96
  • Anchorage, Alaska
  • +75 more
Sep 6, 2012

Lung Cancer, Squamous Cell Carcinoma, Head Neck Cancer Trial in Philadelphia ([F-18] VM4-037)

Completed
  • Lung Cancer
  • +4 more
  • [F-18] VM4-037
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 15, 2010

Renal Cell Carcinoma Trial in United States (Combination of Temsirolimus and Sunitinib)

Terminated
  • Renal Cell Carcinoma
  • Combination of Temsirolimus and Sunitinib
  • Baltimore, Maryland
  • +3 more
Dec 19, 2007